Table 3.
Concordance between IM status from the 101-gene model and IO score from the novel immuno-oncology algorithm within the validation cohort of 335 unique TNBC samples.
101-gene TNBC Model |
|||
---|---|---|---|
IM+ | IM- | ||
IO Algorithm | IO+ | 82 (24%) | 37 (11%) |
IO- | 2 (1%) | 214 (64%) |